Literature DB >> 20092277

First enantiocontrolled formal synthesis of (+)-neovibsanin B, a neurotrophic diterpenoid.

Tomoyuki Esumi1, Takehiro Mori, Ming Zhao, Masao Toyota, Yoshiyasu Fukuyama.   

Abstract

An enantiocontrolled formal synthesis of (+)-neovibsanin B has been achieved by a sequence that applies an asymmetric 1,4-addition of (H(2)C=CH)(2)Cu(CN)Li(2) to trisubstituted alpha,beta-carboxylic acid derivative 1 to induce the chirality at the C-11 all-carbon quaternary center. Together with a modified Negishi cyclic carbopalladation-carbonylative esterification tandem reaction for constructing the A-ring, the synthesis was completed.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20092277     DOI: 10.1021/ol902960n

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  4 in total

Review 1.  Neurotrophic natural products: chemistry and biology.

Authors:  Jing Xu; Michelle H Lacoske; Emmanuel A Theodorakis
Journal:  Angew Chem Int Ed Engl       Date:  2013-12-18       Impact factor: 15.336

2.  Axial preferences in allylations via the Zimmerman-Traxler transition state.

Authors:  Noga Gilboa; Hao Wang; Kendall N Houk; Ilan Marek
Journal:  Chemistry       Date:  2011-06-03       Impact factor: 5.236

3.  Neovibsanin B inhibits human malignant brain tumor cell line proliferation and induces apoptosis.

Authors:  Yi-Fen Cui; Xiao-Lin Yuan; Wen-Hai Fan; Sheng-Fan Li; Yu-Qin Deng; Qing Zhang; Chun-Lei Zhang; Zhen Yang
Journal:  Int J Clin Exp Med       Date:  2015-04-15

4.  Protective effect of neovibsanin B on spatial cognitive functions of rats with cerebrovascular hypoperfusion.

Authors:  Xing-Wang Chen; Yong-Tao Lv; Ye Han; Ying Huan; Xiao-Ya Feng; Chun-Fu Chen
Journal:  Int J Clin Exp Med       Date:  2015-08-15
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.